Invest in exClone
exClone launching VOCTOR, Virtual AI Doctor, 24/7 available & reliable guide.
EARLY BIRD TERMS: $1,650 LEFT
reserved of a $100,000 goal
$8M$5.5Mvaluation cap Future Equity
A Future Equity Agreement (SAFE) gives you the right to future shares in the company. If you invest, you're betting the company will be worth more than $5.5M eventually.
Learn more about SAFEs
I am investing in Voctor.ai & exClone because they are helping solve the need for broad access to high-quality, low-cost, health care simply through the use of an innovative, novel app. They are starting their telemedicine app focused on the greatest need - women's healthcare. The founder and CEO, Riza Berkan, a nuclear physicist and serial entrepreneur, has developed the proprietary truly innovative ai technology specializing in conversational systems, similar to Amazon’s Alexa. With full ownership of their own IP, it's based on an ontological model, which is highly efficient and completely different from traditional ai, which is based on mathematical models. The company has tested its proof-of-concept with several customers in other categories successfully and they are now launching this disruptive medical app to help patients 24/7 effectively and anonymously access a “cloned” medical doctor, VOCTOR, for a virtual consultation and health advisory services in several areas such as infertility, coronavirus, birth control, pregnancy, and breast cancer. As a result of a five-year R&D, their proprietary technology with no third-party IP allows for thousands of users to chat with a virtual expert, simultaneously, about their health concerns and questions.
Invested $5,000 this round
Learn about Lead Investors